Licorice Compound Isoliquiritigenin Linked to Gut-Brain Axis Benefits in Parkinson’s Disease Study

A recent study has identified isoliquiritigenin, a flavonoid found in licorice, as a potential therapeutic agent for Parkinson’s disease. Researchers have observed that this compound may positively impact neurological health by influencing gut microbiota. The findings highlight the connection between dietary components and their role in managing neurodegenerative conditions.

The study focused on isoliquiritigenin’s ability to modulate gut microbiota, which is increasingly recognized as a key factor in neurological disorders. By targeting the gut-brain axis, the flavonoid demonstrated potential in alleviating some symptoms associated with Parkinson’s disease. Researchers suggest that these results could pave the way for further exploration into dietary interventions and their effects on brain health.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: November 30, 2025

Related posts:

University of Cincinnati Researchers Identify Oncogene Mechanisms Driving Lymphoma Growth Western Sydney University Develops AI Tool to Assess Type 1 Diabetes Risk and Treatment Response Bacteriological Testing Market to Reach USD 37.26 Billion by 2030 with 7.6 Percent CAGR Growth FDA Launches Program to Evaluate Surrogate Endpoints for Accelerated Drug Approvals in Cancer and Serious Diseases

Author

GOAI